Adaptive Dc-optimal designs for dose finding based on a continuous efficacy endpoint
From MaRDI portal
Publication:3076087
Recommendations
- Adaptive optimal designs for dose-finding studies based on sigmoid \(E_{\max}\) models
- Adaptive designs for dose-finding based on efficacy-toxicity response
- Optimal response-adaptive designs for continuous responses in phase III trials
- Adaptive Bayesian compound designs for dose finding studies
- Optimal adaptive randomized designs for clinical trials
- Optimal designs for active controlled dose-finding trials with efficacy-toxicity outcomes
- Robust adaptive designs in clinical trails for continuous responses
Cites work
Cited in
(19)- scientific article; zbMATH DE number 7513920 (Why is no real title available?)
- Penalized optimal designs for dose-finding
- On optimal designs for clinical trials: an updated review
- Adaptive isotonic estimation of the minimum effective and peak doses in the presence of covariates
- Adaptive designs for dose-finding based on efficacy-toxicity response
- A comparison of allocation strategies for optimising clinical trial designs under variance heterogeneity
- Locally optimal designs for some dose-response models with continuous endpoints
- Designing dose-finding studies with an active control for exponential families
- Non-parametric optimal design in dose finding studies
- Optimal designs for a multiresponse Emax model and efficient parameter estimation
- On the combination of \(c\)- and \(D\)-optimal designs: general approaches and applications in dose-response studies
- Optimal designs for dose-finding studies
- Multiple-objective optimal designs for studying the dose response function and interesting dose levels
- Dose Finding for Continuous and Ordinal Outcomes with a Monotone Objective Function: A Unified Approach
- Response-adaptive dose-finding under model uncertainty
- Optimal dose‐finding for efficacy–safety models
- Adaptive optimal designs for dose-finding studies based on sigmoid \(E_{\max}\) models
- Adaptive designs for selecting drug combinations based on efficacy-toxicity response
- Design efficiency in dose finding studies
This page was built for publication: Adaptive Dc-optimal designs for dose finding based on a continuous efficacy endpoint
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3076087)